S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
The Healthy Moms and Babies Act (S 2289) aims to improve maternal and infant health outcomes by strengthening Medicaid and CHIP programs. It requires states to report on maternal health quality measures, establishes a new "maternity health home" option for coordinated care during pregnancy and postpartum, and mandates studies on reducing cesarean sections and expanding doula services under Medicaid. The bill also requires states to collect data on social determinants of health affecting pregnant and postpartum women and provides guidance for reducing maternal mortality and severe morbidity. These provisions directly affect pregnant and postpartum women enrolled in Medicaid, healthcare providers, and state Medicaid programs.
This bill (S 1677, Ensuring Lasting Smiles Act) requires health insurance plans to cover medically necessary treatments for congenital anomalies or birth defects affecting the eyes, ears, teeth, mouth, or jaw. It mandates coverage for reconstructive services, dental/orthodontic care, and related treatments during the course of medical treatment, while excluding purely cosmetic procedures not medically necessary. Plans may apply cost-sharing requirements similar to those for other medical services but must provide notice about these coverage requirements to participants by January 1, 2026. The bill also directs a study on provider network adequacy and cost impacts related to these coverage requirements, to be completed by December 2027.
The SPARC Act creates a federal loan repayment program to address specialty healthcare shortages in rural areas. It provides up to $250,000 in repayment for specialty physicians (non-primary care doctors) and non-physician providers (like nurse practitioners) who commit to six years of full-time work in underserved rural communities. Eligible loans include federal education debts like Stafford and Perkins loans, with participants required to serve in designated shortage areas to receive benefits. The program prevents double-benefits with other federal loan forgiveness programs and requires annual reporting on program impact through 2033.
Resident Education Deferred Interest Act or the REDI Act This bill allows borrowers in medical or dental internships or residency programs to defer student loan payments until the completion of their programs.
The HELP Copays Act requires that financial assistance from non-profit organizations or prescription drug manufacturers counts toward patients' annual out-of-pocket cost-sharing limits (like deductibles and copays) for certain prescription drugs. It directly affects individuals enrolled in group health plans or individual insurance who receive such assistance, ensuring payments from these sources reduce their total out-of-pocket spending. The bill amends key healthcare laws to include these payments in calculating cost-sharing thresholds, specifically for specialty drugs and drugs subject to utilization management (like prior authorization). It takes effect for plan years beginning in 2026 and does not change how utilization management tools are applied.
The Child Care Workforce Act (S 846) establishes a federal pilot program to boost pay for eligible child care workers in states, Indian Tribes, and Tribal organizations. It provides competitive grants to fund wage supplements targeting low-wage workers, aiming to attract and retain staff, improve well-being, and increase access to quality, affordable child care - particularly in underserved areas and for infants/toddlers or children with disabilities. Grantees must prioritize funding for high-need regions, pay supplements quarterly, and provide workers with tax/public benefit information, with up to 10% of funds allowed for administrative costs. The program will be evaluated after two years to measure impacts on worker retention, service quality, and affordability.
This bill requires health insurance plans to cover prostate cancer screenings without copays or deductibles for men aged 40+ who are at high risk of prostate cancer. It specifically applies to African-American men and men with a family history of prostate cancer (defined as having a first-degree relative diagnosed with the disease or genetic risk factors). The law amends existing coverage requirements to include these screenings as a preventive service, aiming to address disparities in late-stage diagnosis and improve early detection rates. The policy change takes effect for plan years beginning January 1, 2025.
This bill establishes a formal international disability rights strategy for the U.S. Department of State and creates an Office of International Disability Rights to coordinate disability policy in foreign affairs. The legislation requires the Secretary of State to develop a formal policy within 180 days, consult with disability advocates and affected communities, and submit an annual strategy report to Congress. It also mandates disability training for all State Department personnel, ensures accessibility in U.S. embassies and consulates, and creates a fellowship program to build expertise on disability rights among Foreign Service officers.
The End Veterans Overdose Act of 2026 requires the Department of Veterans Affairs (VA) to provide opioid overdose rescue medications (like naloxone) at no cost and without a prescription to veterans and their designated caregivers at VA pharmacies. It also mandates that veterans and caregivers receive clear information on how to use these medications. The law restricts VA from using personal information collected under this program for employment decisions, as evidence of drug use, or for addiction claims. Additionally, the VA must submit annual reports to Congress detailing how many veterans and caregivers received the medication, assessing potential expansions to family members and non-VA providers, and tracking usage trends.
The LINC VA Act (S 3303) establishes a pilot program to create or enhance a community integration platform at VA medical facilities, helping veterans access coordinated support services like housing, healthcare, job training, and mental health care through partnerships with community organizations. The platform must connect existing local services, use standardized health screening tools (based on ICD-10 codes for social determinants), and track referral outcomes to improve service coordination. It requires the VA to implement this at five or more diverse VA facilities - including rural and under-resourced sites - within one year of enactment. The program collects veteran data on social needs to better align VA care with community resources, with a report due to Congress within three years.
This bill amends VA medical coverage to explicitly include adaptive prostheses and terminal devices designed for sports and recreational activities alongside standard artificial limbs. It directly affects eligible veterans using prosthetic devices who wish to participate in sports or recreational therapy. The key provision expands existing VA coverage under 38 U.S.C. §1701 to cover these specific adaptive devices without requiring separate authorization. This change ensures veterans can access equipment for recreational purposes through the VA's standard medical services. The bill does not create new benefits but clarifies and broadens existing coverage for a defined category of prosthetic devices.
